In Silico Study and Pharmacological Evaluation of Eplerinone as an Anti-Alzheimer's Drug in STZ-Induced Alzheimer's Disease Model.

Table 2 shows that eplerinone-treated mice at doses of 8 and 16 mg/kg showed moderately significant ( P ≤ 0.001) and highly significant ( P ≤ 0.001), ( F = 3.9) improvement in transfer latency (TL), respectively, on the day of assessment.

also in 2,178 other papers